BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• BioCapital

  CEL-SCI Announces Closing Of Public Offering For Gross Proceeds Of $6 Million

  October 24, 2014

   · 

  1 min read
• Global Bioenergies: One Step Closer To Industrial Pilot Testing

  October 24, 2014

   · 

  1 min read
• Mundipharma AG Receives Positive CHMP Opinion For Targin® (Oxycodone / Naloxone) For The Treatment Of Restless Legs Syndrome1

  October 24, 2014

   · 

  3 min read
• Astellas Pharma Inc.'s XTANDI™ (Enzalutamide) Capsules Receive Positive CHMP Opinion For The Treatment Of Men With Metastatic Castration-Resistant Prostate Cancer Who Are Chemotherapy-Naïve

  October 24, 2014

   · 

  5 min read
• Drug Development

  Verastem, Inc. Presents New Data On Mesothelioma Programs At The 12th International Mesothelioma Interest Group Meeting

  October 24, 2014

   · 

  9 min read
• Business

  BIOCOM Announces 2014 Elected Official Of The Year

  October 24, 2014

   · 

  2 min read
• ERYtech Pharma: Prospectus Made Available After Obtaining Visa N° 14-566 From The French Financial Markets Authority

  October 24, 2014

   · 

  1 min read
• Genetown

  Ariad Pharmaceuticals, Inc. Announces Adoption of Final Opinion For Iclusig By Committee For Medicinal Products For Human Use In Europe

  October 24, 2014

   · 

  5 min read
• Drug Development

  Clovis Oncology Announces First Patient Enrolled In Lucitanib Phase 2 Study In Squamous Non-small Cell Lung Cancer

  October 24, 2014

   · 

  5 min read
• FDA

  Europe Approves Clinuvel’s Novel Australian Drug Developed For Rare Sun Disease

  October 24, 2014

   · 

  3 min read